Brain Implants Market Scope And Analysis

  • Report Code : TIPHE100001259
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 205
Buy Now

Brain Implants Market Analysis, Trends, and Scope 2023 to 2030

Buy Now

Brain Implants Market Report Brain Implants Market Size and Share Brain Implants Market Scope and Analysis

Brain Implants Market Report Scope

Report Attribute Details
Market size in 2022 US$ 7.21 Billion
Market Size by 2030 US$ 17.65 Billion
Global CAGR (2022 - 2030) 11.8%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Treatment
  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulator
  • Invasive and Non-Invasive Brain
By Application
  • Chronic Pain
  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy
  • Essential Tremor
  • Depression
  • Dystonia
  • Amyotrophic Lateral Sclerosis
  • Neurofibromatosis 2
By End User
  • Hospitals and Specialized Clinics/Neurological Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Boston Scientific Corp
  • Medtronic Plc
  • Functional Neuromodulation Ltd
  • Fisher Wallace Laboratories Inc
  • Synchron Inc
  • Blackrock Microsystems Inc
  • Renishaw Plc
  • Abbott Laboratories
  • Neurospine LLC

    • Industry Developments and Future Opportunities:

    Various initiatives taken by key players operating in the global brain implants market are listed below:

    1. In June 2023, Boston Scientific Corp received US FDA approval for the Vercise Neural Navigator 5 Software, which is used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems. It provides clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson’s disease or essential tremor.
    2. In January 2021, Medtronic plc announced the enrollment in ADAPT-PD (Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease) to evaluate the safety and efficacy of adaptive DBS in patients with Parkinson's Disease.

    Competitive Landscape and Key Companies:

    Boston Scientific Corporation, Medtronic, Abbott (St. Jude Medical), Renishaw Plc., NeuroPace Inc., Aleva Neurotherapeutics, Functional Neuromodulation Inc., Fisher Wallace, NeuroSpine, Cortec Neuro, Neuro Sky, Neuralink, Synchron, Blackrock Neurotech, BrainGate, Wisper AI, Onward Medical, and Paradromics are among the prominent players in the brain implants market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.